BLAINE JACKSON: Open Payments
NPI 1518079565 · SOLANA BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,546 in 68 payments from 16 companies in 2025. Trend: 2023 $1,319 · 2024 $1,184 · 2025 $2,546
Food & beverage: $2,534Education: $9Travel & lodging: $2
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 15 | $530 |
| Lilly USA, LLC | 10 | $458 |
| Teva Pharmaceuticals USA, Inc. | 8 | $308 |
| Otsuka America Pharmaceutical, Inc. | 4 | $280 |
| PFIZER INC. | 8 | $250 |
| ABBVIE INC. | 4 | $200 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
Products named: NUPLAZID, AUSTEDO XR, REXULTI, NURTEC ODT, ZEPBOUND, UBRELVY, KISUNLA, COBENFY.
Industry payments across CA — which companies pay providers there.
